Investor Relations January 24, 2023 Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory Read More
Investor Relations November 14, 2022 Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder Read More
Investor Relations September 20, 2022 Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering Read More
Investor Relations September 15, 2022 Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial Public Offering Read More
